Old Web
English
Sign In
Acemap
>
authorDetail
>
Doug Bevan
Doug Bevan
Novartis
Pyrazole
Biochemistry
Chemistry
Activator (genetics)
Nitric oxide
2
Papers
9
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
The Discovery of (S)-1-(6-(3-((4-(1-(Cyclopropanecarbonyl)piperidin-4-yl)-2-methylphenyl)amino)-2,3-dihydro-1H-inden-4-yl)pyridin-2-yl)-5-methyl-1H-pyrazole-4-carboxylic Acid, a Soluble Guanylate Cyclase Activator Specifically Designed for Topical Ocular Delivery as a Therapy for Glaucoma
2018
Journal of Medicinal Chemistry
Takeru Ehara
Christopher M. Adams
Doug Bevan
Nan Ji
Erik Meredith
David Belanger
James J. Powers
Mitsunori Kato
Catherine Solovay
Donglei Liu
Michael Paul Capparelli
Philippe Bolduc
Jonathan E. Grob
Matthew H. Daniels
Luciana Ferrara
Louis Yang
Byron Li
Christopher Towler
Rebecca C. Stacy
Ganesh Prasanna
Muneto Mogi
Show All
Source
Cite
Save
Citations (9)
Dérivés d'acide thiophène-2-yl-pyridine-2-yl -1h-pyrazole-4-carboxylique et leur utilisation comme activateurs de la guanylate cyclase soluble
2015
Christopher M. Adams
David Belanger
Doug Bevan
Takeru Ehara
Luciana Ferrara
Nan Ji
Mitsunori Kato
Donglei Liu
Erik Meredith
Muneto Mogi
James J. Powers
Ganesh Prasanna
Show All
Source
Cite
Save
Citations (0)
1